Persistence With Biologic Therapy and Associated Costs of Patients With Inflammatory Bowel Disease: A German Retrospective Claims Data Analysis.

Mahlich, Joerg; May, Melanie; Feig, Chiara; Straub, Vincent; Schmelz, Renate

Mahlich, Joerg; May, Melanie; Feig, Chiara; Straub, Vincent; Schmelz, Renate.

Afiliação

Mahlich J; Health Economics and Outcomes Research, Janssen-Cilag GmbH, Neuss, Germany.
May M; Düsseldorf Institute for Competition Economics (DICE), DICE, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Feig C; Health Economics, HGC Healthcare Consultants GmbH, Duesseldorf, Germany.
Straub V; Health Economics, HGC Healthcare Consultants GmbH, Duesseldorf, Germany.
Schmelz R; Health Economics, HGC Healthcare Consultants GmbH, Duesseldorf, Germany.

Crohns Colitis 360 ; 3(2): otab011, 2021 Apr.

Article em En | MEDLINE | ID: mdl-36778945

Palavras-chave

German claims data; biologic therapy; inflammatory bowel disease; real-world data; treatment persistence; tumor necrosis factor α-inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Crohns Colitis 360 Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google